학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 181건 | 목록 1~20
Academic Journal
Bauchau V; Independent, Previously GSK, Vaccine Safety, Wavre, Belgium.; Bollaerts K; P95 (Epidemiology and Pharmacovigilance Consultant and Services), Leuven (Flemish Brabant), Belgium.; Bryan P; GSK (Safety Evaluation and Risk Management), London, UK.; Buttery J; Murdoch Childrens Research Institute, University of Melbourne, Melbourne, VIC, Australia.; Davis K; Janssen Research and Development LLC (Global Epidemiology), Horsham, PA, USA.; Chen RT; Brighton Collaboration (A Program of the Task Force for Global Health), Decatur, GA, USA.; Feikin DR; World Health Organization, Geneva, Switzerland.; Fretta A; Pfizer (Worldwide Medical & Safety), New York, NY, USA.; Frise S; AstraZeneca (Global Patient Safety), Mississauga, ON, Canada. Sarah.frise@astrazeneca.com.; Gandhi-Banga S; Sanofi (Global Pharmacovigilance), Toronto, ON, Canada.; Izurieta HS; US Food and Drug Administration (Center for Biologics Evaluation and Research), Silver Spring, MD, USA.; Jouquelet-Royer C; Sanofi (Patient Safety and Pharmacovigilance), Lyon, Auvergne-Rhone-Alpes, France.; Khromava A; Sanofi (Global Pharmacovigilance), Toronto, ON, Canada.; Li L; Sanofi (Epidemiology and Benefit Risk), Bridgewater, NJ, USA.; Long R; Independent, Previously Bill & Melinda Gates Foundation (Safety & Pharmacovigilance), London, UK.; MacDonald S; Pfizer (Worldwide Medical & Safety), New York, NY, USA.; Marcelon L; Sanofi (Epidemiology and Benefit Risk Evaluation), Lyon, Auvergne-Rhone-Aples, France.; Massouh R; GSK (Safety Evaluation and Risk Management), London, UK.; Meeraus W; AstraZeneca (Medical Evidence, Vaccines & Immune Therapies), Cambridge, UK.; Munoz FM; Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.; Naim K; Pfizer (Worldwide Medical & Safety), New York, NY, USA.; Nordenberg D; Thriive.AI, Bronx, NY, USA.; Nohynek H; National Institute for Health and Welfare (Infectious Diseases Control and Vaccines), Helsinki, Finland.; Rubino H; Pfizer (Worldwide Medical & Safety), New York, NY, USA.; Salmon DA; School of Public Health (Department of International Health, Institute for Vaccine Safety), Johns Hopkins Bloomberg, Baltimore, MD, USA.; Sellers S; Novavax (Safety Science and Surveillance), Gaithersburg, MD, USA.; Serradell L; Sanofi (Epidemiology and Benefit Risk Evaluation), Lyon, Auvergne-Rhone-Aples, France.; Torcel-Pagnon L; Sanofi (Vaccines Medical Global Evidence Generation Influenza), Lyon, Auvergne-Rhone-Alpes, France.; Wilkins J; Pfizer (Worldwide Medical & Safety), New York, NY, USA.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE; In Process
Academic Journal
Stergachis A; University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA. stergach@uw.edu.; Safety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA. stergach@uw.edu.; Sevene E; Safety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.; Eduardo Mondlane University, Maputo, Mozambique.; Alam MGS; University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA.; Safety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.; Chandler RE; Coalition for Epidemic Preparedness Innovation (CEPI), Oslo, Norway.; Precioso A; Coalition for Epidemic Preparedness Innovation (CEPI), Oslo, Norway.; Mudigonda S; Safety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.; Thriive, New York, NY, USA.; Nordenberg D; Safety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.; Thriive, New York, NY, USA.; Chen RT; Safety Platform for Emergency Vaccines (SPEAC), Decatur, GA, USA.; Brighton Collaboration, The Task Force for Global Health, Decatur, GA, USA.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Academic Journal
Mues KE; Aetion, Inc. New York, NY, United States. Electronic address: Katie.mues@aetion.com.; Zhou CK; Moderna, lnc. Cambridge, MA, United States.; Gerber JE; Eliassen Group, Baltimore, MD, United States.; van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH's-Hertogenbosch, the Netherlands; Department of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713, AV, Groningen, the Netherlands.; Klein NP; Kaiser Permanente Vaccine Study Center, Division of Research, Kaiser Permanente Northern California, Oakland, CA, United States.; Izurieta HS; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA), United States.; Chen RT; Brighton Collaboration, The Task Force for Global Health, Atlanta, GA, United States of America.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Academic Journal
Diray-Arce J; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA. Electronic address: joann.arce@childrens.harvard.edu.; Chang AC; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.; Moradipoor S; Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada.; Amodio D; Clinical and Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.; Carleton B; Department of Pediatrics and BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC V5Z 4H4, Canada.; Chang WC; Department of Pediatrics and BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC V5Z 4H4, Canada.; Crawford NW; Murdoch Children's Research Institute (MCRI_AEFI-CAN) & University of Melbourne, Parkville, VIC 3052, Australia.; Karoly M; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.; Hoch A; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.; McEnaney K; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.; Kafil TS; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Donthireddy M; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.; Steltz SK; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA.; van Haren SD; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA.; Angelidou A; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA; Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.; Smolen KK; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA.; Steen H; Harvard Medical School, Boston, MA 02115, USA; Department of Pathology, Boston Children's Hospital, Boston, MA 02115, USA.; Lasky-Su J; Harvard Medical School, Boston, MA 02115, USA; Channing Division of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.; Tran H; Monash University, Melbourne, VIC 3004, Australia.; Liu P; University of Ottawa Heart Institute, Ottawa, ON K1W 4W7, Canada.; Creech CB; Vaccine Research Program, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Cutland CL; African Leadership in Vaccinology Expertise (Wits-Alive), Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg 2050, South Africa.; Petousis-Harris H; Global Vaccine Data Network and School of Population Health, University of Auckland, 1142, New Zealand.; Nazy I; Department of Medicine McMaster University, Hamilton, ON L8S 4K1, Canada; Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario L8S 4K1, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8S 4K1, Canada.; Yeung RSM; Cell and Systems Biology Research Program, The Hospital for Sick Children, Departments of Paediatrics, Immunology and Institute of Medical Sciences, University of Toronto, Toronto, ON M5G 1X8, Canada.; Kochhar S; Global Healthcare Consulting, New Delhi 110024, India; University of Washington, Seattle, WA 98915, USA.; Black S; Global Vaccine Data Network and School of Population Health, University of Auckland, 1142, New Zealand.; Wood N; University of Sydney, Sydney, NSW 2006, Australia.; Nordenberg D; Thriive, Bronx, NY, USA; Safety Platform for Emergency vACcines (SPEAC), Brighton Collaboration, The Task Force for Global Health, Decatur, GA 30030, USA.; Palma P; Clinical and Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.; Ovsyannikova IG; Vaccine Research Group, Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Kennedy RB; Vaccine Research Group, Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Poland GA; Vaccine Research Group, Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Ozonoff A; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Chen RT; Brighton Collaboration, Task Force for Global Health, Decatur, GA 30030, USA.; Levy O; Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Top KA; Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada; Li Ka Shing Institute of Virology and Women's and Children's Health Research Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada; Departments of Community Health & Epidemiology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Editorial & Opinion
Huang WT; Brighton Collaboration, Task Force for Global Health, Decatur, USA.; Chen RT; Brighton Collaboration, Task Force for Global Health, Decatur, USA.; Cassard C; Brighton Collaboration, Task Force for Global Health, Decatur, USA. ccassard@taskforce.org.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Academic Journal
Salmon DA; Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.; Chen RT; Brighton Collaboration, A program of the Task Force for Global Health, Decatur, GA, USA.; Black S; Global Vaccine Data Network, Auckland, New Zealand.; Sharfstein J; Department of Health, Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-764X (Electronic) Linking ISSN: 14740338 NLM ISO Abbreviation: Expert Opin Drug Saf Subsets: MEDLINE
Academic Journal
Spurgers K; Emergent Product Development Gaithersburg Inc, Gaithersburg, MD, USA.; Wynn M; Emergent Product Development Gaithersburg Inc, Gaithersburg, MD, USA.; Charles L; Emergent Product Development Gaithersburg Inc, Gaithersburg, MD, USA.; Hamm S; Auro Vaccines LLC, Pearl River, NY, USA.; Matassov D; Auro Vaccines LLC, Pearl River, NY, USA.; Gerardi C; Auro Vaccines LLC, Pearl River, NY, USA.; Smith ER; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org.; Gurwith M; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.; Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Academic Journal
Link EK; Ludwig-Maximilians-University Munich (LMU Munich), Department of Veterinary Sciences, Division of Virology, Oberschleißheim, Germany.; Tscherne A; Ludwig-Maximilians-University Munich (LMU Munich), Department of Veterinary Sciences, Division of Virology, Oberschleißheim, Germany.; Sutter G; Ludwig-Maximilians-University Munich (LMU Munich), Department of Veterinary Sciences, Division of Virology, Oberschleißheim, Germany.; Smith ER; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org.; Gurwith M; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA.; Chen RT; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA.; Volz A; University of Veterinary Medicine Hannover, Institute of Virology, Hannover, Germany.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Academic Journal
Pather S; BioNTech SE, Mainz, Germany.; Charpentier N; BioNTech SE, Mainz, Germany.; van den Ouweland F; BioNTech SE, Mainz, Germany.; Rizzi R; BioNTech SE, Mainz, Germany.; Finlayson A; BioNTech SE, Mainz, Germany.; Salisch N; BioNTech SE, Mainz, Germany.; Muik A; BioNTech SE, Mainz, Germany.; Lindemann C; BioNTech SE, Mainz, Germany.; Khanim R; BioNTech SE, Mainz, Germany.; Abduljawad S; BioNTech SE, Mainz, Germany.; Smith ER; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: bc-coordinator@taskforce.org.; Gurwith M; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.; Chen RT; Brighton Collaboration, a program of the Task Force for Global Health, Decatur, GA, USA.
Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Academic Journal
Salmon DA; From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the University of Pennsylvania, Philadelphia (S.A.P.); and the Brighton Collaboration, Task Force for Global Health, Decatur, GA (R.T.C.).; Orenstein WA; From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the University of Pennsylvania, Philadelphia (S.A.P.); and the Brighton Collaboration, Task Force for Global Health, Decatur, GA (R.T.C.).; Plotkin SA; From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the University of Pennsylvania, Philadelphia (S.A.P.); and the Brighton Collaboration, Task Force for Global Health, Decatur, GA (R.T.C.).; Chen RT; From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the University of Pennsylvania, Philadelphia (S.A.P.); and the Brighton Collaboration, Task Force for Global Health, Decatur, GA (R.T.C.).
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Chen, Robert T
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어